Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,289.20
(
-1.74%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
2.42%
)
Bitcoin
79,094.47
(
-2.42%
)
News Focus
News Focus
Post# of 257577
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 141640

Wednesday, 05/09/2012 4:26:51 PM

Wednesday, May 09, 2012 4:26:51 PM

Post# of 257577

Teva did not formally change its guidance given in Dec 2011 for $3.8B of worldwide Copaxone sales in 2012

Teva did not formally change any of its previous guidance and gave the excuse that the new CEO Levin needs more time and I guess he will lower the targets.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today